Literature DB >> 31780841

Immuno-oncology drug development goes global.

Jia Xin Yu, Vanessa M Hubbard-Lucey, Jun Tang.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31780841     DOI： 10.1038/d41573-019-00167-9

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  63 in total

1.  Immune checkpoint inhibition: from molecules to clinical application.

Authors:  L S Taams; T D de Gruijl
Journal:  Clin Exp Immunol       Date:  2020-05       Impact factor: 4.330

Review 2.  The evolution of interventional oncology in the 21st century.

Authors:  Thomas Helmberger
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.039

Review 3.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

4.  Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not？.

Authors:  Pu Xiaoyu; Ge Chao; Dong Lihua; Chang Pengyu
Journal:  Gut Microbes       Date:  2020-03-27

Review 5.  Scientifically based combination therapies with immuno-oncology checkpoint inhibitors.

Authors:  Hui Yi Chew; Riccardo Dolcetti; Fiona Simpson
Journal:  Br J Clin Pharmacol       Date:  2020-06-18       Impact factor: 4.335

Review 6.  Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities.

Authors:  Colby S Shemesh; Joy C Hsu; Iraj Hosseini; Ben-Quan Shen; Anand Rotte; Patrick Twomey; Sandhya Girish; Benjamin Wu
Journal:  Mol Ther       Date:  2020-09-30       Impact factor: 11.454

Review 7.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Authors:  Javid Moslehi; Andrew H Lichtman; Arlene H Sharpe; Lorenzo Galluzzi; Richard N Kitsis
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

8.  Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC).

Authors:  Helen X Chen; Minkyung Song; Holden T Maecker; Sacha Gnjatic; David Patton; J Jack Lee; Stacey J Adam; Radim Moravec; Xiaole Shirley Liu; Ethan Cerami; James Lindsay; Ming Tang; F Stephen Hodi; Catherine J Wu; Ignacio I Wistuba; Gheath Al-Atrash; Chantale Bernatchez; Sean C Bendall; Stephen M Hewitt; Elad Sharon; Howard Streicher; Rebecca A Enos; Melissa D Bowman; Valerie M Tatard-Leitman; Beatriz Sanchez-Espiridion; Srinika Ranasinghe; Mina Pichavant; Diane M Del Valle; Joyce Yu; Sylvie Janssens; Jenny Peterson-Klaus; Cathy Rowe; Gerold Bongers; Robert R Jenq; Chia-Chi Chang; Jeffrey S Abrams; Margaret Mooney; James H Doroshow; Lyndsay N Harris; Magdalena Thurin
Journal:  Clin Cancer Res       Date:  2021-01-08       Impact factor: 12.531

Review 9.  Cationic Nanoparticle-Based Cancer Vaccines.

Authors:  Jeroen Heuts; Wim Jiskoot; Ferry Ossendorp; Koen van der Maaden
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

10.  Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review.

Authors:  Houssein Safa; Monica Tamil; Philippe E Spiess; Brandon Manley; Julio Pow-Sang; Scott M Gilbert; Firas Safa; Brian D Gonzalez; Laura B Oswald; Adele Semaan; Adi Diab; Jad Chahoud
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.